Transcript
Page 1: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

1

Basic Salivary Gland Pathology

1

Basic Salivary Gland PathologyJennifer L. Hunt, MD, MEd

Aubrey J. Hough Jr, MD, Endowed Professor of PathologyChair of Pathology and Laboratory MedicineUniversity of Arkansas for Medical Sciences

[email protected]

Agenda

• Common benign lesions• Warthins tumor

• Pleomorphic adenoma

• Basal cell adenoma

2

• Myoepithelioma

• Common Malignancies• Mucoepidermoid carcinoma variants

• Adenoid cystic carcinoma

• Carcinoma ex pleomorphic adenoma

• Salivary duct carcinoma

Salivary Glands Background

• Major salivary glands• Parotid

• Submandibular gland

• Sublingual gland

3

• Minor salivary glands• Throughout respiratory tract

Page 2: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

2

4Parotid Gland Submandibular Gland

4

Warthin Tumor

5

Warthin Tumor

• Incidence• Related to smoking

• Can be bilateral

• Parotid, minor salivary glands, rests

6

• Clinical• Mass lesion, benign

Page 3: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

3

Warthin Tumor

• Gross• Cystic lesion

• Fluid resembles motor oil

• Histology

7

• Oncocytic epithelium

• Papillary growth

• Lymphoid stroma• Germinal centers

8Warthin tumor

9Warthin tumor

Page 4: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

4

Pleomorphic Adenoma

10

Pleomorphic Adenoma

• Incidence• Most common benign tumor

• Clinical• Mass lesion

11

• Surgical treatment with margins

Pleomorphic Adenoma

• Gross• Bosselated

• Chondroid

• Histology: Mixed

12

• Stromal: chondroid, hyalinized, myxoid

• Epithelial cells: ducts and tubules

• Myoepithelial cells

Page 5: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

5

13Pleomorphic adenoma

14Pleomorphic adenoma

15Pleomorphic adenoma

Page 6: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

6

Pleomorphic Adenoma

• IHC• Myoepithelial markers positive (GFAP)

• Ki-67: low proliferative rate (<5%)

• Prognosis

16

• Local recurrence: 5-10%

• Malignant degeneration: 5%-25%• “Carcimoma ex pleomorphic adenoma”

Recurrent Pleomorphic adenoma

18Recurrent Pleomorphic adenoma

Page 7: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

7

Pleomorphic Adenoma

• Differential diagnosis• Basal cell adenoma

• Unique morphology

• Myoepithelioma N h d id t b l

19

• No chondroid, no tubules

Basal Cell Adenoma

• Histology: Solid, trabecular, tubular• Two cell types

• Small, dark nuclei with pallisading

• Larger, lighter nuclei, islands and cords

Distinct basement membrane

20

• Distinct basement membrane

• No chondromyxoid stroma

• Immunohistochemistry• Epithelial and myoepithelial cells

• Positive for respective markers

• GFAP negative

21Basal cell adenoma

Page 8: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

8

22Basal cell adenoma

Basal Cell Adenoma

• Histology• Membranous type (Dermal Analogue tumor)

• Similar to dermal cylindroma (“turban tumor”)

• Epithelial islands

• Peripheral small basophilic palisading cells

23

• Peripheral small basophilic palisading cells

• Central large cells, squamoid whorls

• Extracellular hyaline material

Basal cell adenoma

Page 9: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

9

Myoepithelioma

25

Myoepithelioma

• Incidence• Probably under-recognized

• Clinical• Mass lesion

26

Myoepithelioma

• Histology: Pure myoepithelial cells• No ducts/tubules

• No chondroid matrix

• Hyalinized and myxoid matrix

27

• Myoepithelial cells• Spindle, epithelioid, clear, mixed

Page 10: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

10

28Myoepithelioma, clear cells

29Myoepithelioma, S100

Myoepithelioma

• IHC• Positive for myoepithelial markers

• Variable cytokeratin staining

• Negative for CEA

30

Page 11: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

11

Myoepithelial Cells

• Morphologically diverse

• Variable immunohistochemical stains

31

32

Myoepithelial Markers

Usually positive Positive or negative Usually negative

AE1-3 SMA EMA

Vimentin SMMH CEA

S100 CK14 CK7

33

Calponin Cam5.2 B72.3

P63 CK5/6 Desmin

CK903 Maspin HHF-35

CD10 GFAP

Page 12: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

12

Myoepithelioma

• Differential diagnosis• Myoepithelial carcinoma

• Invasive

• Pleomorphism, mitoses, atypia

Clear cell h alini ing carcinoma

34

• Clear cell hyalinizing carcinoma• CEA positive

Agenda

• Common benign lesions• Warthins tumor

• Pleomorphic adenoma

• Basal cell adenoma

35

• Myoepithelioma

• Common Malignancies• Mucoepidermoid carcinoma variants

• Adenoid cystic carcinoma

• Carcinoma ex pleomorphic adenoma

• Salivary duct carcinoma

Mucoepidermoid Carcinoma

• Incidence• Most common malignant salivary gland tumor

(children and adults)

• Major and minor salivary glands

P k i id 5th t 6th d d

36

• Peak incidence 5th to 6th decades

• Clinical• Mass lesion

• Surgical treatment with margins

Page 13: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

13

Histology

• Mucus cells and cysts

• Epidermoid cells

37

• Intermediate cells

38Mucus cells and Cysts

Mucus cells and Cysts

Page 14: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

14

E

40Cell types

I M

E

Tumor Grading

• Tumor specific grading• Defined features

• General gradingR bl t l

41

• Resemblance to normal• Nuclear features

• Grade by definition

Salivary Gland Tumors

Tumor specific General grading Grading by Definition

Mucoepidermoid Oncocytic i

Salivary Duct i

42

carcinoma carcinoma

Adenoid cystic carcinoma

Adenocarcinoma, NOS

Polymorphous low-grade

No Grading

Acinic cell carcinoma

Page 15: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

15

Mucoepidermoid Translocation

• t(11;19)(q21;p13)

• MECT1-MAML2• MECT1: also known as CRTC1, TORC1,

WAMTP1

43

• cAMP response element binding protein (CREB) regulated transcriptional coactivator

• MAML2: Notch coactivator

• Translocation activates Notch target genes independent of Notch ligands

MECT-MAML2 Translocation

44

Courtesy of Dr. Sanja DacicUniversity of Pittsburgh

Adenoid Cystic Carcinoma

• Incidence• Relatively common

• Any salivary gland location

• Clinical

45

• Mass lesion

• Nerve palsies

• Surgical treatment with margins

Page 16: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

16

Adenoid Cystic Carcinoma

• Histology• Tubular, cribriform, solid patterns

• Solid has worse behavior

• Perineural invasion

N l i ll d k d l t d

46

• Nuclei small, dark, and angulated

47Adenoid cystic carcinoma, cribriform

48Adenoid cystic carcinoma, tubular

Page 17: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

17

49Adenoid cystic carcinoma, solid

50Adenoid cystic carcinoma

Page 18: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

18

Adenoid Cystic Carcinoma, perineural invasion

Adenoid Cystic Carcinoma

• IHC• CKIT and bcl-2 positive

• Epithelial cells: cytokeratins

• Myoepithelial cells: p63, SMA, CK5/6

53

High Grade Transformation

• Clinical• Tumor progression with aggressive disease

• May have clinical history of adenoid cystic carcinoma

Hi t l

54

• Histology• Low grade areas and high grade areas

• Epithelial predominance

• Necrosis

• Vascular invasion

Page 19: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

19

High Grade Transformation

40%

60%45% 45%

55

0%

20%

Alive & Well Recurrence Death from disease

10%

Seethala RR, AJSP 3(11):1683, 2007

Adenoid cystic carcinoma with high grade transformation

57Adenoid cystic carcinoma with high grade transformation

Page 20: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

20

Solid adenoid cystic carcinoma

Adenoid cystic carcinoma high grade transformation

High Grade Transformation

• Immunohistochemistry• Loss of myoepithelial component

• SMA, p63, calponin negative

• All cells stain with cytokeratin

Strong p53 staining

59

• Strong p53 staining

• High proliferative rate (Ki-67)

AE1-3

Page 21: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

21

p63

Ki-67

p53

Page 22: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

22

Adenoid Cystic Translocation

• t(6;9) (q22-23; p23-24)

• MYB-NFIB• MYB

• Transcription factor with an important role in cell proliferation, apoptosis, and differentiation

64

• Highly expressed in immature proliferating cells, and down-regulated as cells become more differentiated

• NFIB: nuclear factor 1B

• Deregulation mechanism is not completely understood

Translocation in ACC

60%

80%

100%

Translocation

65

0%

20%

40%

Adenoid cystic Other salivary tumors

Translocation

No translocation

Abnormal

West R, Am J Surg Pathol 2011;35:92–99

Carcinoma ex Pleomorphic Adenoma

66

Page 23: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

23

Carcinoma ex Pleomorphic Adenoma

• Incidence: Relatively rare

• Etiology: Arises from PA

• Clinical• Long standing mass with recent rapid

67

g g penlargement

• History of PA • Resected incompletely

• Recurrent

Carcinoma ex Pleomorphic Adenoma

• Histology• Residual pleomorphic adenoma

• Carcinoma component• Specific salivary carcinoma (any type)

Ad i NOS

68

• Adenocarcinoma, NOS

• IHC• Specific to type of carcinoma

69Carcinoma ex pleomorphic adenoma

Page 24: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

24

70Carcinoma ex pleomorphic adenoma

Salivary Duct Carcinoma

71

Salivary Duct Carcinoma

• Incidence: Rare

• Clinical• Aggressive clinical course

• Metastases at presentation

72

• Surgical treatment

• Chemotherapy & radiation

Page 25: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

25

Salivary Duct Adenocarcinoma

• Histology• Resembles breast carcinoma

• Cribriform, micropapillary, solid

• Comedo-type necrosis

• Micro and macro calcifications

73

• Micro and macro calcifications

• Stromal and perineural invasion

74Salivary duct carcinoma

75Salivary duct carcinoma

Page 26: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

26

76Salivary duct carcinoma

Salivary Duct Carcinoma

• IHC• Androgen receptor positive

• HER2/neu positive

• PSA occasionally positive

77

• ER/PR usually negative

78SDC, HER2/NEU SDC, Androgen

Page 27: Basic Salivary Gland Pathology · Basic Salivary Gland Pathology 1 Basic Salivary Gland Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology

27

Summary

• Common benign lesions• Warthins tumor

• Pleomorphic adenoma

• Basal cell adenoma

79

• Myoepithelioma

• Common Malignancies• Mucoepidermoid carcinoma variants

• Adenoid cystic carcinoma

• Carcinoma ex pleomorphic adenoma

• Salivary duct carcinoma


Recommended